Next Article in Journal
C-Reactive Protein Is a Potential Prognostic Marker in Patient with Advanced or Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multi-Center Retrospective Study
Previous Article in Journal
Integration of Computational Pipeline to Streamline Efficacious Drug Nomination and Biomarker Discovery in Glioblastoma
Previous Article in Special Issue
Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel
 
 
Communication

Article Versions Notes

Cancers 2024, 16(9), 1722; https://doi.org/10.3390/cancers16091722
Action Date Notes Link
article xml file uploaded 28 April 2024 12:00 CEST Original file -
article xml uploaded. 28 April 2024 12:00 CEST Update https://www.mdpi.com/2072-6694/16/9/1722/xml
article pdf uploaded. 28 April 2024 12:00 CEST Version of Record https://www.mdpi.com/2072-6694/16/9/1722/pdf
article supplementary file uploaded. 28 April 2024 12:00 CEST - https://www.mdpi.com/2072-6694/16/9/1722#supplementary
article html file updated 28 April 2024 12:02 CEST Original file https://www.mdpi.com/2072-6694/16/9/1722/html
Back to TopTop